Waldecker Markus, Kautenburger Tanja, Daumann Heike, Busch Cordula, Schrenk Dieter
Food Chemistry and Environmental Toxicology, University of Kaiserslautern, D-67663 Kaiserslautern, Germany.
J Nutr Biochem. 2008 Sep;19(9):587-93. doi: 10.1016/j.jnutbio.2007.08.002. Epub 2007 Dec 3.
Colorectal cancer is the most abundant cause of cancer mortality in the Western world. Nutrition and the microbial flora are considered to have a marked influence on the risk of colorectal cancer, the formation of butyrate and other short-chain fatty acids (SCFAs) possibly playing a major role as chemopreventive products of microbial fermentation in the colon. In this study, we investigated the effects of butyrate, other SCFAs, and of a number of phenolic SCFA and trans-cinnamic acid derivatives formed during the intestinal degradation of polyphenolic constituents of fruits and vegetables on global histone deacetylase (HDAC) activity in nuclear extracts from colon carcinoma cell cultures using tert-butoxycarbonyl-lysine (acetylated)-4-amino-7-methylcoumarin (Boc-Lys(Ac)-AMC) as substrate. Inhibition of HDAC activity, e.g., by butyrate, is related to a suppression of malignant transformation and a stimulation of apoptosis of precancerous colonic cells. In nuclear extracts from HT-29 human colon carcinoma cells, butyrate was found to be the most potent HDAC inhibitor (IC50=0.09 mM), while other SCFAs such as propionate were less potent. In the same assay, p-coumaric acid (IC50=0.19 mM), 3-(4-OH-phenyl)-propionate (IC50=0.62 mM) and caffeic acid (IC50=0.85 mM) were the most potent HDAC inhibitors among the polyphenol metabolites tested. Interestingly, butyrate was also the most potent HDAC inhibitor in a whole-cell HeLa Mad 38-based reporter gene assay, while all polyphenol metabolites and all other SCFAs tested were much less potent; some were completely inactive. The findings suggest that butyrate plays an outstanding role as endogenous HDAC inhibitor in the colon, and that other SCFAs and HDAC-inhibitory polyphenol metabolites present in the colon seem to play a much smaller role, probably because of their limited levels, their marked cytotoxicity and/or their limited intracellular availability.
在西方世界,结直肠癌是导致癌症死亡的最主要原因。营养和微生物菌群被认为对结直肠癌风险有显著影响,丁酸及其他短链脂肪酸(SCFAs)的形成可能在结肠微生物发酵的化学预防产物中起主要作用。在本研究中,我们以叔丁氧羰基赖氨酸(乙酰化)-4-氨基-7-甲基香豆素(Boc-Lys(Ac)-AMC)为底物,研究了丁酸、其他短链脂肪酸以及水果和蔬菜中多酚成分在肠道降解过程中形成的一些酚类短链脂肪酸和反式肉桂酸衍生物对结肠癌细胞培养核提取物中全局组蛋白脱乙酰酶(HDAC)活性的影响。HDAC活性的抑制,例如丁酸引起的抑制,与恶性转化的抑制以及癌前结肠细胞凋亡的刺激有关。在HT-29人结肠癌细胞的核提取物中,发现丁酸是最有效的HDAC抑制剂(IC50 = 0.09 mM),而其他短链脂肪酸如丙酸的效力则较弱。在同一试验中,对香豆酸(IC50 = 0.19 mM)、3-(4-羟基苯基)丙酸(IC50 = 0.62 mM)和咖啡酸(IC50 = 0.85 mM)是测试的多酚代谢产物中最有效的HDAC抑制剂。有趣的是,在基于HeLa Mad 38的全细胞报告基因试验中,丁酸也是最有效的HDAC抑制剂,而所有测试的多酚代谢产物和所有其他短链脂肪酸的效力则低得多;有些完全没有活性。这些发现表明,丁酸在结肠中作为内源性HDAC抑制剂发挥着突出作用,而结肠中存在的其他短链脂肪酸和HDAC抑制性多酚代谢产物似乎发挥的作用要小得多,可能是因为它们的水平有限、明显的细胞毒性和/或细胞内可用性有限。